Radical Prostatectomy as a First-Line Treatment in Patients with Initial PSA  >20 ng/mL

Table 5

Oncological outcome at the 10th year after surgery in patients with favorable combination of prognostic variables (pT2, N0) versus patients with unfavorable prognostic variables (pT3-4 and/or N1).

Patient group	BCR-free survival		Overall survival		Cancer-specific survival
	% Censored cases	KM estimates (10th year)	% Censored cases	KM estimates (10th year)	% Censored cases	KM estimates (10th year)
Favorable (pT2, N0)	71.4%	44.3%	90.5%	72.0%	100.0%	100.0%
Unfavorable (pT3-4 and/or N1)	43.4%	0%	81.1%	33.6%	81.1%	33.6%
𝑃 value	0.001		0.097		0.011